Fact CheckerSign in

NCT06100991Active, not recruiting

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
3 Oct 2023
Start date
19 Sept 2023
Primary completion date
Dec 2099
Lead sponsor
CorEvitas
Diseases
Psoriasis
NCT number
NCT06100991

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 19 Sept 2023 to the primary completion date, Dec 2099
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any of the following would exclude the subject from participating in the registry:
    • Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP.
    • Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry

Who the study is looking for

  • A subject must meet all the following criteria to participate in the registry:
    • Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.
    • Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.
    • Is willing to provide consent for participation in the registry.
    • Is willing to provide Personal Information

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CorEvitas, LLC
Coordinator of this site? Confirm its status
WalthamUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.